Julian F. Dye

Swainsonine, a glycosylation inhibitor, enhances both lymphocyte efficacy and tumour susceptibility in LAK and NK cytotoxicity

Christine Galustian, Sharmila Foulds, Julian F. Dye et al. · Immunopharmacology · 1994 · 48 citations

Tumor Biology, Medicine, Glycosylation Inhibitor +9

The release of soluble adhesion molecules ICAM-1 and E-selectin after acute myocardial infarction and following coronary angioplasty

Tomasz Siminiak, Julian F. Dye, R Egdell et al. · International Journal of Cardiology · 1997 · 31 citations

Thrombosis, Percutaneous Coronary Intervention, Cardiovascular Disease +10

Plasma-Mediated Neutrophil Activation during Acute Myocardial Infarction: Role of Platelet-Activating Factor

Tomasz Siminiak, R Egdell, D. J. O'Gorman et al. · Clinical Science · 1995 · 26 citations

Actin cytoskeletal isoforms in human endothelial cellsin vitro: Alteration with cell passage

Christine Galustian, Julian F. Dye, Lopa Leach et al. · In Vitro Cellular & Developmental Biology - Animal · 1995 · 20 citations

Cell Passage, Cell Adhesion, Physiology +8

Human Immunodeficiency Virus Infection Abolishes CD4-dependent Activation of ZAP-70 by Inhibition of p56lck

Christine Guntermann, Julian F. Dye, Keith E. Nye · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 1997 · 17 citations

Immunology, Antiviral Drug, Immunotherapy +16